---
title: "DZ BANK AG Sticks to Its Buy Rating for Sanofi (SNYNF)"
description: "According to TipRanks, Kraus is a 4-star analyst with an average return of 8.7% and a 70.77% success rate. Kraus covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Novo Nordisk"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262668306.md"
published_at: "2025-10-24T16:25:13.000Z"
---

# DZ BANK AG Sticks to Its Buy Rating for Sanofi (SNYNF)

> According to TipRanks, Kraus is a 4-star analyst with an average return of 8.7% and a 70.77% success rate. Kraus covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Novo Nordisk, and Sanofi. Sanofi has an analyst consensus of Strong Buy, with a price target consensus of $123.55, representing a 22.37% upside. In a report released today, Jefferies also maintained a Buy rating on the stock with a €120.00 price target.

According to TipRanks, Kraus is a 4-star analyst with an average return of 8.7% and a 70.77% success rate. Kraus covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Novo Nordisk, and Sanofi.

Sanofi has an analyst consensus of Strong Buy, with a price target consensus of $123.55, representing a 22.37% upside. In a report released today, Jefferies also maintained a Buy rating on the stock with a €120.00 price target.

### Related Stocks

- [SNYNF.US - Sanofi](https://longbridge.com/en/quote/SNYNF.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Sanofi Plans Expansion of Global Capability Center in India | Sanofi Plans Expansion of Global Capability Center in India | [Link](https://longbridge.com/en/news/276093503.md) |
| Fitch Maintains Ratings of Hikma, Roche Following Corporate Rating Criteria Updates | Fitch Maintains Ratings of Hikma, Roche Following Corporate Rating Criteria Updates | [Link](https://longbridge.com/en/news/275874477.md) |
| Novo Nordisk A/S - share repurchase programme | Novo Nordisk A/S has initiated a share repurchase programme of up to DKK 15 billion, starting from 4 February 2026. As o | [Link](https://longbridge.com/en/news/276056741.md) |
| Sanofi Healthcare India expands Hyderabad GCC to grow capabilities and drive innovation | Sanofi Healthcare India expands Hyderabad GCC to grow capabilities and drive innovation | [Link](https://longbridge.com/en/news/276048003.md) |
| Roche Appoints Mark Dawson As New Head Of Roche Pharma Research And Early Development | Roche Holding AG :ROCHE HOLDING AG - APPOINTMENT OF MARK DAWSON, M.D., PH.D., AS NEW HEAD OF ROCHE PHARMA RESEARCH AND E | [Link](https://longbridge.com/en/news/276097246.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.